AHA/ASA Issues Guidance for Optimal Stroke Care During COVID-19 Pandemic
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
Vascular Neurology
Predictive Factors and Outcomes of Late Cerebrovascular Events Post TAVR
Researchers explored the incidence, clinical characteristics, associated factors, and clinical outcomes of late cerebrovascular events >30- days after TAVR.
Predictors of Atrial Fibrillation in Patients With Transient Ischemic Attack
Patients with transient ischemic attack with high brain natriuretic peptide values are more likely to have atrial fibrillation.
Abnormal Cerebral Blood Flow May Influence the Etiology of Parkinson Disease
Patients with Parkinson disease tend to have an increase in iron content with reduced perfusion in the substantia nigra.
MRI-Based Small Vessel Disease Score Predicts Risk for Dementia
A simple SVD score using MRI scans, may aid in identifying patients with SVD who are likely to develop cognitive decline.
Statin-Associated Risk for Intracerebral Hemorrhage in Patients With Prior Stroke
Treatment with statins is not associated with increased risk for ICH in patients with a history of stroke, and may even decrease the risk for ICH in some of these patients.
Reperfusion Outcomes in Stroke Patients Treated With Idarucizumab
Treatment with idarucizumab can safely facilitate stroke thrombolysis in dabigatran-treated patients, with similar outcomes as patients who did not require idarucizumab therapy.
Use of Double Layer Stent With Proximal Cerebral Protection in CAS Offers Best Outcome
Carotid artery stenting performed with the double-layer Roadsaver stent and proximal protection using the Mo.Ma Ultra device was found to be associated with
the best outcomes, in terms of microembolic signals, in high-risk patients with lipid-rich plaques.
Outcomes of Mechanical Thrombectomy in Patients on Oral Anticoagulants
The clinical outcomes following mechanical thrombectomy appears to be better in patients on direct oral anticoagulants, compared to vitamin K antagonists.
Brain Amyloid Deposition and Intracranial Atherosclerotic Disease in Adults
There is no evidence for an association between cerebral β-amyloid deposition, a marker of Alzheimer disease, and intracranial atherosclerotic plaque or stenosis.
Next post in Alzheimer's Disease and Dementia
